Edition:
United States

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

3.40USD
15 Dec 2017
Change (% chg)

$-0.03 (-0.87%)
Prev Close
$3.43
Open
$3.40
Day's High
$3.42
Day's Low
$3.38
Volume
105,914
Avg. Vol
3,195
52-wk High
$5.76
52-wk Low
$3.37

Select another date:

Wed, Nov 22 2017

BRIEF-Evogene Q3 loss per share $0.20

* Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million

BRIEF-Evogene posts Q2 ‍loss per share $0.18​

* ‍Total revenues for Q2 of 2017 were $1.2 million, compared to $1.8 million for Q2 in 2016​

BRIEF-Evogene ltd - entered into a multiyear collaboration with DuPont Pioneer

* Evogene Ltd - entered into a multiyear collaboration with DuPont Pioneer

BRIEF-Evogene Ltd reaches an important milestone in its crop disease collaboration with Monsanto Company​

* Evogene Ltd- ‍company reached an important milestone in its crop disease collaboration with Monsanto Company​

BRIEF-Evogene announces positive results in insect control seed trait program

* Evogene Ltd announces positive results in insect control seed trait program and advancement to Phase-I of First Toxin against Western Corn Rootworm

Select another date: